Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Melanoma of the Skin (Late Stage^), 2015-2019

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Name
State
 sort alphabetically by name ascending
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank⋔
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count descending
Percent of Cases with Late Stage
 sort by percent late descending
US (SEER+NPCR) 1 3.1 (3.1, 3.1) N/A 11,646 13.6
Wyoming 6 3.8 (3.1, 4.5) 10 (1, 39) 25 15.2
Wisconsin 6 3.5 (3.3, 3.7) 16 (8, 28) 243 14.6
West Virginia 6 3.6 (3.2, 4.0) 15 (2, 32) 85 16.2
Washington 5 3.1 (2.9, 3.3) 30 (19, 40) 261 11.8
Virginia 6 2.9 (2.8, 3.1) 36 (25, 42) 283 14.1
Vermont 6 3.8 (3.2, 4.5) 9 (1, 39) 30 9.7
Utah 3 4.7 (4.3, 5.0) 1 (1, 4) 128 11.3
Texas 3 2.6 (2.5, 2.7) 43 (40, 46) 735 18.6
Tennessee 6 3.4 (3.3, 3.6) 19 (10, 29) 272 16.4
South Dakota 6 3.1 (2.6, 3.6) 33 (8, 48) 31 11.7
South Carolina 6 2.9 (2.7, 3.1) 40 (26, 44) 175 12.4
Rhode Island 6 3.7 (3.2, 4.2) 11 (2, 35) 48 16.0
Puerto Rico 6 0.6 (0.5, 0.7) N/A 24 17.2
Pennsylvania 6 3.5 (3.3, 3.6) 18 (11, 25) 563 15.5
Oregon 6 2.8 (2.6, 3.1) 41 (26, 45) 140 10.8
Oklahoma 6 3.3 (3.1, 3.6) 23 (11, 37) 145 15.1
Ohio 6 3.9 (3.7, 4.0) 6 (2, 13) 539 15.1
North Dakota 6 3.4 (2.8, 4.0) 21 (2, 46) 27 14.3
North Carolina 6 3.1 (2.9, 3.2) 34 (23, 40) 363 11.5
New York 3 2.5 (2.4, 2.6) 46 (43, 49) 586 13.8
New Mexico 3 2.4 (2.1, 2.7) 47 (40, 49) 60 13.9
New Jersey 3 2.7 (2.5, 2.8) 42 (38, 47) 292 12.4
New Hampshire 6 4.1 (3.7, 4.6) 2 (1, 19) 69 12.4
Nebraska 6 3.8 (3.4, 4.2) 8 (2, 25) 81 13.3
Montana 6 3.6 (3.1, 4.1) 14 (2, 40) 47 12.6
Missouri 6 3.2 (3.1, 3.4) 25 (13, 36) 231 17.1
Mississippi 6 3.1 (2.9, 3.4) 27 (15, 41) 105 16.8
Minnesota 6 3.4 (3.2, 3.6) 20 (10, 31) 215 9.7
Michigan 6 3.3 (3.2, 3.5) 22 (14, 32) 395 16.1
Massachusetts 3 3.1 (2.9, 3.3) 32 (20, 41) 256 14.7
Maryland 6 2.5 (2.3, 2.7) 45 (40, 49) 174 9.9
Maine 6 3.3 (2.9, 3.7) 24 (6, 41) 60 12.3
Louisiana 3 2.5 (2.3, 2.7) 44 (40, 49) 131 13.8
Kentucky 3 3.9 (3.6, 4.1) 7 (2, 17) 200 13.7
Kansas 6 3.1 (2.8, 3.4) 28 (13, 41) 102 11.2
Iowa 3 4.0 (3.7, 4.3) 3 (1, 14) 148 13.7
Indiana 6 4.0 (3.8, 4.2) 4 (2, 12) 302 18.2
Illinois 3 3.1 (3.0, 3.2) 31 (22, 39) 456 14.0
Idaho 3 3.7 (3.3, 4.1) 12 (2, 30) 71 12.7
Hawaii 3 2.3 (2.0, 2.6) 48 (40, 50) 41 9.6
Georgia 3 3.0 (2.8, 3.1) 35 (25, 41) 328 11.2
Florida 6 3.5 (3.4, 3.6) 17 (11, 24) 988 13.3
District of Columbia 6 1.5 (1.1, 2.0) 50 (48, 50) 10 14.5
Delaware 6 3.9 (3.4, 4.5) 5 (1, 29) 46 12.8
Connecticut 3 2.9 (2.7, 3.1) 39 (23, 44) 129 14.5
Colorado 6 3.7 (3.5, 3.9) 13 (4, 22) 223 16.6
California 3 2.9 (2.8, 3.0) 38 (32, 41) 1,249 12.6
Arkansas 6 3.2 (2.9, 3.5) 26 (12, 41) 114 13.6
Arizona 6 2.9 (2.8, 3.1) 37 (26, 42) 249 10.5
Alaska 6 2.1 (1.6, 2.6) 49 (39, 50) 14 14.3
Alabama 6 3.1 (2.9, 3.3) 29 (17, 41) 179 13.7
Nevada 6
data not available
N/A
data not available
data not available
Notes:
Created by statecancerprofiles.cancer.gov on 12/08/2022 9:44 pm.

State Cancer Registries may provide more current or more local data.

Data cannot be shown for the following areas. For more information on what areas are suppressed or not available, please refer to the table.
Nevada

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
Data not available for this combination of data selections.

Source: SEER and NPCR data. For more specific information please see the table.

Interpret Rankings provides insight into interpreting cancer incidence statistics. When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate.

Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top